TBPH Stock Summary and Trading Ideas (Theravance Biopharma - | NASDAQ:TBPH)

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Theravance Biopharma - trades on the NASDAQ stock market under the symbol TBPH.

As of September 25, 2026, TBPH stock price was flat at $17.03 with million shares trading.

TBPH has a beta of 0.76, meaning it tends to be less sensitive to market movements. TBPH has a correlation of 0.05 to the broad based SPY ETF.

TBPH has a market cap of $884.18 million. This is considered a Small Cap stock.

Last quarter Theravance Biopharma - reported $21 million in Revenue and $.18 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.10.

In the last 3 years, TBPH traded as high as $21.03 and as low as $7.44.

The top ETF exchange traded funds that TBPH belongs to (by Net Assets): VTI, VXF, VTWO, VHT, VTWG.

TBPH has outperformed the market in the last year with a return of +23.5%, while the SPY ETF gained +18.4%. However, in the most recent history, TBPH shares have underperformed the stock market with its stock returning -2.1% in the last 3 month period and +0.1% for the last 2 week period, while SPY has returned +5.3% and +1.2%, respectively.

TBPH support price is $16.99 and resistance is $17.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBPH shares will trade within this expected range on the day.